Clinical Trial Update: Optimum Misoprostol Dose Prior to Office Hysteroscopy [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the optimal misoprostol dose before office hysteroscopy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding
• Infertility
• Pregnancy Loss

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Cairo University | Conditions: Infertility, Abnormal Uterine and Vaginal Bleeding, Unspecified | Phase 3 | Status: COMPLETED